NGS library prep market seen reaching $3.17 billion by 2030

The next-generation sequencing library preparation market is projected to grow from $1.63 billion in 2025 to $3.17 billion by 2030, driven by gene therapy, automated workflows and expanding genomic research. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - Next-generation sequencing library preparation is a core step in genomic testing, supporting more accurate sequencing for healthcare, medicine and biological research. - The market’s growth signals rising demand for tools that can handle expanding clinical diagnostics, personalized medicine and advanced genomic studies.

What happened: - The Business Research Company released its 2026 report on the global next-generation sequencing library preparation market. - The market is projected to grow from $1.63 billion in 2025 to $1.86 billion in 2026. - The report forecasts the market will reach $3.17 billion by 2030. - The report was published Aug. 19, 2026, from London. - Download a free sample of the report. - View the full market report.

The details: - NGS library preparation processes DNA or RNA samples so they can be read by sequencing machines. - The process replicates genetic material and adds tags that help sequencing systems organize and interpret data. - The report links historical market growth to sequencing throughput limits, high kit costs, manual workflows, rising genomic research demand and broader clinical use. - The report cites automated library preparation platforms, growing whole-genome and exome sequencing, more investment in personalized medicine, expanded academic genomics projects and integration with AI and cloud analytics as future growth drivers. - The market is expected to grow at a 14.5% CAGR from 2025 to 2026. - The forecast period to 2030 implies a 14.2% CAGR. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

Between the lines: - Gene therapy is becoming a key demand driver because it depends on precise genetic analysis and validation. - IQVIA said spending on cell and gene therapies reached $5.9 billion in 2023, up 38% from the prior year. - That spending represented 0.4% of $1.6 trillion in global medicine expenditure, underscoring how quickly the category is scaling from a small base. - The report’s new 2026 features include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics, and updated graphics and tables.

What's next: - Automated workflows, AI-linked analytics and broader adoption of whole-genome and exome sequencing are expected to keep lifting demand. - Faster growth in Asia-Pacific could shift more market activity toward regions expanding genomics infrastructure and research capacity. - The report frames personalized medicine and academic genomics investment as longer-term demand anchors.

The bottom line: - NGS library preparation is moving from a technical lab step to a growing commercial market tied to the expansion of precision medicine and genomic research.